Hospital
Victor Valley Hospital Acquisition, INC.
Victor Valley Hospital Acquisition, INC. was paid $26.63M by Medicaid between Jan 2018 and Dec 2024, across 231 billing codes. Its largest line is 0450, Emergency room services — 15% of everything it billed.
33Billing provider infoVICTOR VALLEY HOSPITAL ACQUISITION, INC.
VICTORVILLE, CA 92395
VICTORVILLE, CA 92395
33aNPI1679879589assigned 02/10/2011
33bProvider typeGeneral Acute Care Hospital
28Total paid$26.63M
24GClaims910,732
24DCodes billed231
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in California
Rank by total paid#98 of 410
Median peer was paid$6.90M
This provider vs. median3.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official THOMAS, WILLIAM controls 14+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 120,411 | $2.74M | |
| 2019 | 146,971 | $3.45M | |
| 2020 | 113,746 | $3.27M | |
| 2021 | 114,790 | $3.53M | |
| 2022 | 124,043 | $4.60M | |
| 2023 | 155,019 | $4.95M | |
| 2024incomplete | 135,752 | $4.09M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0450 | Emergency room services | 15% | 77,641 | 68,835 | $3.94M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 10% | 47,961 | 43,185 | $2.77M |
| 70450 | Computed tomography, head or brain; without contrast material | 5.6% | 10,140 | 9,828 | $1.49M |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 4.7% | 17,287 | 14,401 | $1.26M |
| 0360 | 3.8% | 8,682 | 5,087 | $1.02M | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 3.4% | 27,106 | 24,661 | $896K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 3.3% | 7,233 | 7,047 | $875K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3.2% | 3,748 | 3,638 | $849K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3.0% | 11,952 | 11,305 | $802K |
| 80053 | Comprehensive metabolic panel | 3.0% | 45,949 | 42,219 | $788K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.6% | 53,778 | 48,690 | $685K |
| 99221 | 1.8% | 2,760 | 2,729 | $473K |
219 more codes
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.8% | 15,942 | $471K |
| 99070 | 1.5% | 68,765 | $403K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 1.4% | 2,009 | $378K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.3% | 6,302 | $355K |
| Z7502 | 1.3% | 9,285 | $336K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.2% | 7,548 | $324K |
| 49322 | 1.2% | 1,522 | $309K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 2,753 | $257K |
| 0762 | <1% | 4,169 | $242K | |
| 58558 | <1% | 3,058 | $234K | |
| G0378 | Hospital observation service, per hour | <1% | 3,577 | $227K |
| 70486 | <1% | 1,380 | $223K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 3,646 | $220K |
| 84484 | <1% | 12,633 | $211K | |
| L8699 | Prosthetic implant, not otherwise specified | <1% | 42 | $186K |
| 71045 | Radiologic examination, chest; single view | <1% | 15,808 | $185K |
| 99499 | <1% | 4,797 | $181K | |
| 0710 | <1% | 5,712 | $174K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 2,940 | $170K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 2,516 | $168K |
| J3490 | Unclassified drugs | <1% | 44,568 | $164K |
| 76801 | <1% | 2,678 | $158K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 2,812 | $157K |
| 83690 | <1% | 13,886 | $154K | |
| 93971 | <1% | 1,380 | $148K | |
| 83880 | <1% | 4,827 | $144K | |
| 81025 | <1% | 20,215 | $141K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 1,840 | $133K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 1,570 | $131K |
| 59025 | Fetal non-stress test | <1% | 5,512 | $125K |
| 81015 | <1% | 23,385 | $123K | |
| 84702 | <1% | 5,900 | $119K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 5,788 | $117K |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 1,680 | $115K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 502 | $115K |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 2,068 | $111K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 4,022 | $106K |
| 84703 | <1% | 8,009 | $105K | |
| 72131 | <1% | 624 | $100K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 4,588 | $100K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 2,918 | $96K |
| 58662 | <1% | 463 | $95K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 1,051 | $82K |
| 99284 | Emergency room visit (serious) | <1% | 1,203 | $81K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 5,426 | $78K |
| 87088 | <1% | 9,028 | $77K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,507 | $75K |
| 82553 | <1% | 4,102 | $74K | |
| 85730 | <1% | 7,490 | $74K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 2,150 | $73K |
| 83605 | <1% | 4,116 | $72K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 5,719 | $69K |
| 49329 | <1% | 271 | $63K | |
| 99285 | Emergency room visit (most serious) | <1% | 725 | $59K |
| 99218 | <1% | 276 | $56K | |
| 73130 | <1% | 2,020 | $54K | |
| 76770 | <1% | 697 | $53K | |
| 73610 | <1% | 2,004 | $53K | |
| 81003 | <1% | 15,900 | $53K | |
| 73030 | <1% | 1,967 | $53K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 13,225 | $51K |
| 73630 | <1% | 2,043 | $50K | |
| 58563 | <1% | 580 | $48K | |
| 85610 | <1% | 7,769 | $47K | |
| 87040 | <1% | 1,782 | $47K | |
| 73562 | <1% | 1,947 | $47K | |
| Z9725 | <1% | 1,249 | $47K | |
| A4217 | Sterile water/saline, 500 ml | <1% | 2,892 | $46K |
| 90715 | <1% | 1,364 | $46K | |
| 87077 | <1% | 5,588 | $45K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,555 | $45K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,474 | $39K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 856 | $38K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 434 | $38K |
| 58670 | <1% | 168 | $34K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 21,755 | $32K |
| 72100 | <1% | 1,043 | $31K | |
| 82150 | <1% | 2,947 | $31K | |
| 85378 | <1% | 2,479 | $30K | |
| 73110 | <1% | 1,106 | $29K | |
| 74018 | <1% | 1,248 | $27K | |
| 83735 | <1% | 2,527 | $27K | |
| 86850 | <1% | 2,149 | $25K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 3,974 | $22K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 4,239 | $22K |
| 58300 | <1% | 583 | $22K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 3,141 | $22K |
| 76999 | <1% | 77 | $21K | |
| Z7610 | <1% | 1,703 | $21K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 2,870 | $20K |
| 87420 | <1% | 1,521 | $20K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 14,703 | $19K |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | <1% | 1,765 | $19K |
| 49320 | <1% | 97 | $19K | |
| 58671 | <1% | 112 | $19K | |
| Q4100 | Skin substitute, not otherwise specified | <1% | 12 | $18K |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 4,623 | $17K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 246 | $16K |
| 93970 | <1% | 78 | $16K | |
| 85027 | <1% | 1,637 | $15K | |
| 86901 | <1% | 2,179 | $14K | |
| 0100U | <1% | 419 | $13K | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 5,379 | $13K |
| 72040 | <1% | 505 | $13K | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 6,835 | $13K |
| 99224 | <1% | 140 | $11K | |
| 87181 | <1% | 4,604 | $10K | |
| 99217 | <1% | 280 | $10K | |
| 73090 | <1% | 459 | $10K | |
| 86900 | <1% | 2,149 | $10K | |
| 73080 | <1% | 358 | $10K | |
| 87070 | <1% | 984 | $9K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 107 | $8K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 384 | $8K |
| 73590 | <1% | 381 | $8K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 7,702 | $8K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,331 | $7K |
| 87631 | <1% | 108 | $7K | |
| 80321 | <1% | 429 | $6K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 375 | $6K |
| 73502 | <1% | 206 | $6K | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 3,866 | $5K |
| 88304 | <1% | 264 | $5K | |
| 0750 | <1% | 49 | $5K | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | <1% | 2,761 | $5K |
| 82803 | <1% | 154 | $5K | |
| 0370 | <1% | 29 | $4K | |
| 12001 | <1% | 295 | $4K | |
| 71250 | <1% | 25 | $4K | |
| 82550 | <1% | 360 | $4K | |
| S0164 | Injection, pantoprazole sodium, 40 mg | <1% | 428 | $4K |
| 0270 | <1% | 1,717 | $4K | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 2,562 | $4K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 189 | $4K |
| 0250 | <1% | 2,177 | $4K | |
| 86780 | <1% | 258 | $4K | |
| 73140 | <1% | 190 | $3K | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 1,716 | $3K |
| 73700 | <1% | 15 | $3K | |
| 71101 | <1% | 91 | $3K | |
| 86140 | <1% | 354 | $3K | |
| 29125 | <1% | 519 | $3K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 14 | $3K |
| 71020 | <1% | 128 | $3K | |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | <1% | 511 | $3K |
| 80305 | <1% | 288 | $3K | |
| 81305 | <1% | 21 | $3K | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 572 | $3K |
| 29515 | <1% | 315 | $3K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 41 | $2K |
| 12002 | <1% | 142 | $2K | |
| J0360 | Injection, hydralazine hcl, up to 20 mg | <1% | 374 | $2K |
| J0500 | Injection, dicyclomine hcl, up to 20 mg | <1% | 57 | $2K |
| 12011 | <1% | 111 | $2K | |
| 76870 | <1% | 37 | $2K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 947 | $2K |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | <1% | 80 | $2K |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 2,959 | $1K |
| 96376 | <1% | 26 | $1K | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 1,214 | $1K |
| 71010 | <1% | 88 | $1K | |
| 72128 | <1% | 13 | $1K | |
| J1630 | Injection, haloperidol, up to 5 mg | <1% | 453 | $1K |
| 58301 | <1% | 41 | $1K | |
| 99152 | <1% | 30 | $1K | |
| 99199 | Unlisted special service, procedure or report | <1% | 26 | $1K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 47 | $1K |
| 87210 | <1% | 161 | $1K | |
| 96368 | <1% | 40 | $1K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 16 | $1K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,723 | $1K |
| J2704 | Injection, propofol, 10 mg | <1% | 4,121 | $994.36 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 422 | $971.93 |
| J2310 | Injection, naloxone hydrochloride, per 1 mg | <1% | 48 | $882.96 |
| 72110 | <1% | 14 | $801.64 | |
| S0077 | Injection, clindamycin phosphate, 300 mg | <1% | 86 | $731.94 |
| J1953 | Injection, levetiracetam, 10 mg | <1% | 786 | $719.72 |
| 73552 | <1% | 26 | $716.16 | |
| J1815 | Injection, insulin, per 5 units | <1% | 438 | $654.06 |
| 86631 | <1% | 38 | $624.31 | |
| 76937 | <1% | 27 | $596.02 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,698 | $526.56 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 13 | $512.70 |
| 82140 | <1% | 29 | $503.40 | |
| 73060 | <1% | 20 | $426.36 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 2,100 | $416.05 |
| 86592 | <1% | 67 | $357.96 | |
| C9113 | Injection, pantoprazole sodium, per vial | <1% | 43 | $326.81 |
| 72072 | <1% | 13 | $317.22 | |
| 84550 | <1% | 47 | $315.27 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 346 | $256.37 |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 59 | $241.63 |
| 83874 | <1% | 13 | $225.54 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 12 | $224.82 |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 27 | $220.17 |
| 85652 | <1% | 41 | $199.70 | |
| 88300 | <1% | 70 | $195.78 | |
| 99153 | Mod sedat endo service >5yrs | <1% | 16 | $138.86 |
| 88302 | <1% | 13 | $138.18 | |
| 29505 | <1% | 14 | $122.16 | |
| 85384 | <1% | 14 | $118.37 | |
| 0272 | <1% | 218 | $116.49 | |
| J0461 | Injection, atropine sulfate, 0.01 mg | <1% | 427 | $110.49 |
| J3105 | Injection, terbutaline sulfate, up to 1 mg | <1% | 60 | $94.69 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 12 | $83.51 |
| 82009 | <1% | 12 | $80.45 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 66 | $77.87 |
| 82728 | <1% | 13 | $61.26 | |
| J0456 | Injection, azithromycin, 500 mg | <1% | 15 | $60.45 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 44 | $56.54 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | <1% | 27 | $33.99 |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | <1% | 42 | $13.56 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 33 | $12.33 |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | <1% | 29 | $11.39 |
| J7510 | Prednisolone oral, per 5 mg | <1% | 74 | $8.34 |
| Q9963 | High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml | <1% | 13 | $3.28 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 28 | $3.00 |
| 80329 | 0% | 32 | $0.00 | |
| Q4051 | Splint supplies, miscellaneous (includes thermoplastics, strapping, fasteners, padding and other supplies) | 0% | 29 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTHOMAS, WILLIAM (SECRETARY)
| Provider | Location | Paid |
|---|---|---|
| Trusted Nurse Staffing | Buffalo, NY | $85.30M |
| KPC Global Medical Centers, INC. | Hemet, CA | $29.34M |
| KPC Global Medical Centers, INC. | Sun City, CA | $8.91M |
| Orange County Global Medical Center, INC | Santa Ana, CA | $8.60M |
| Pediatric and Adolescent Dentistry, LLC | Birmingham, AL | $5.29M |
| South Coast Global Medical Center, INC | Santa Ana, CA | $4.53M |
| Anaheim Global Medical Center, INC | Anaheim, CA | $4.29M |
| South Coast Global Medical Center, INC | Santa Ana, CA | $3.98M |
| Chapman Global Medical Center, INC | Orange, CA | $2.92M |
| Chapman Global Medical Center, INC | Orange, CA | $761K |
| New Creek Family Medicine PLLC | Keyser, WV | $580K |
| Delaware Neurology Associates,pa | Lewes, DE | $75K |
| Anaheim Global Medical Center, INC | Anaheim, CA | $20K |
| Orange County Global Medical Center, INC | Santa Ana, CA | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.